CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation
Siqi Chen(City of Hope), Mingye Feng(California Institute for Regenerative Medicine)
Cited by 30
Related Papers
Programmed cell removal by calreticulin in tissue homeostasis and cancer
|Nature Communications|2018|158
Harnessing and Enhancing Macrophage Phagocytosis for Cancer Therapy
|Frontiers in Immunology|2021|90
ADCdb: the database of antibody–drug conjugates
|Nucleic Acids Research|2023|69